Issue 248
Welcome back to E&O: SaMD, a paying subscribers-only weekly newsletter focused on the world of digital pharma products, prescription digital therapeutics and other FDA-regulated digital health.
E&O: Software as a Medical Device
Here's one quick note before we dig into a company looking to bring a new ADHD digital therapeutic to market as well as the latest updates on digital health-related clinical trials... but first...
- The FDA